Spruce Biosciences, Inc. Common Stock (SPRB) is a publicly traded the market company. As of May 21, 2026, SPRB trades at $52.56 with a market cap of $138.92M and a P/E ratio of -1.02. SPRB moved +7.09% today. Year to date, SPRB is -37.27%; over the trailing twelve months it is +429.99%. Its 52-week range spans $4.28 to $240.00. Analyst consensus is strong buy with an average price target of $178.60. Rallies surfaces SPRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SPRB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SPRB recently traded at $52.56. Market cap is $138.92M. P/E ratio is -1.02. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $52.56 |
| Market Cap | $138.92M |
| P/E Ratio | -1.02 |
| EPS | $-50.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $240.00 |
| 52-Week Low | $4.28 |
| Volume | 34 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-38.97M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-38.97M | $-50.83 |
| 2024 | $4.91M | $-53.04M | $-1.29 |
| 2023 | $10.09M | $-47.92M | $-1.24 |
| 2022 | $0 | $-46.18M | $-1.96 |
5 analysts cover SPRB: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $178.60.